Pharma & Healthcare

Global Major Depressive Disorder Drug Market Research Report 2025

The global market for Major Depressive Disorder Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Major Depressive Disorder Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Major Depressive Disorder Drug.
The Major Depressive Disorder Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Major Depressive Disorder Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Major Depressive Disorder Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bristol-Myers Squibb Company
Cerecor Inc.
e-Therapeutics Plc
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
H. Lundbeck A/S
Hua Medicine Ltd.
Intra-Cellular Therapies, Inc.
Segment by Type
Aripiprazole
AV-101
AVP-786
Basimglurant
Brexpiprazole
Others
Segment by Application
Hospital
Clinic
Research Center
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Major Depressive Disorder Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Major Depressive Disorder Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
1 Major Depressive Disorder Drug Market Overview
1.1 Product Definition
1.2 Major Depressive Disorder Drug by Type
1.2.1 Global Major Depressive Disorder Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Aripiprazole
1.2.3 AV-101
1.2.4 AVP-786
1.2.5 Basimglurant
1.2.6 Brexpiprazole
1.2.7 Others
1.3 Major Depressive Disorder Drug by Application
1.3.1 Global Major Depressive Disorder Drug Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.4 Global Major Depressive Disorder Drug Market Size Estimates and Forecasts
1.4.1 Global Major Depressive Disorder Drug Revenue 2020-2031
1.4.2 Global Major Depressive Disorder Drug Sales 2020-2031
1.4.3 Global Major Depressive Disorder Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Major Depressive Disorder Drug Market Competition by Manufacturers
2.1 Global Major Depressive Disorder Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Major Depressive Disorder Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Major Depressive Disorder Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Major Depressive Disorder Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Major Depressive Disorder Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Major Depressive Disorder Drug, Product Type & Application
2.7 Global Key Manufacturers of Major Depressive Disorder Drug, Date of Enter into This Industry
2.8 Global Major Depressive Disorder Drug Market Competitive Situation and Trends
2.8.1 Global Major Depressive Disorder Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Major Depressive Disorder Drug Players Market Share by Revenue
2.8.3 Global Major Depressive Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Major Depressive Disorder Drug Market Scenario by Region
3.1 Global Major Depressive Disorder Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Major Depressive Disorder Drug Sales by Region: 2020-2031
3.2.1 Global Major Depressive Disorder Drug Sales by Region: 2020-2025
3.2.2 Global Major Depressive Disorder Drug Sales by Region: 2026-2031
3.3 Global Major Depressive Disorder Drug Revenue by Region: 2020-2031
3.3.1 Global Major Depressive Disorder Drug Revenue by Region: 2020-2025
3.3.2 Global Major Depressive Disorder Drug Revenue by Region: 2026-2031
3.4 North America Major Depressive Disorder Drug Market Facts & Figures by Country
3.4.1 North America Major Depressive Disorder Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Major Depressive Disorder Drug Sales by Country (2020-2031)
3.4.3 North America Major Depressive Disorder Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Major Depressive Disorder Drug Market Facts & Figures by Country
3.5.1 Europe Major Depressive Disorder Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Major Depressive Disorder Drug Sales by Country (2020-2031)
3.5.3 Europe Major Depressive Disorder Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Major Depressive Disorder Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Major Depressive Disorder Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Major Depressive Disorder Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Major Depressive Disorder Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Major Depressive Disorder Drug Market Facts & Figures by Country
3.7.1 Latin America Major Depressive Disorder Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Major Depressive Disorder Drug Sales by Country (2020-2031)
3.7.3 Latin America Major Depressive Disorder Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Major Depressive Disorder Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Major Depressive Disorder Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Major Depressive Disorder Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Major Depressive Disorder Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Major Depressive Disorder Drug Sales by Type (2020-2031)
4.1.1 Global Major Depressive Disorder Drug Sales by Type (2020-2025)
4.1.2 Global Major Depressive Disorder Drug Sales by Type (2026-2031)
4.1.3 Global Major Depressive Disorder Drug Sales Market Share by Type (2020-2031)
4.2 Global Major Depressive Disorder Drug Revenue by Type (2020-2031)
4.2.1 Global Major Depressive Disorder Drug Revenue by Type (2020-2025)
4.2.2 Global Major Depressive Disorder Drug Revenue by Type (2026-2031)
4.2.3 Global Major Depressive Disorder Drug Revenue Market Share by Type (2020-2031)
4.3 Global Major Depressive Disorder Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Major Depressive Disorder Drug Sales by Application (2020-2031)
5.1.1 Global Major Depressive Disorder Drug Sales by Application (2020-2025)
5.1.2 Global Major Depressive Disorder Drug Sales by Application (2026-2031)
5.1.3 Global Major Depressive Disorder Drug Sales Market Share by Application (2020-2031)
5.2 Global Major Depressive Disorder Drug Revenue by Application (2020-2031)
5.2.1 Global Major Depressive Disorder Drug Revenue by Application (2020-2025)
5.2.2 Global Major Depressive Disorder Drug Revenue by Application (2026-2031)
5.2.3 Global Major Depressive Disorder Drug Revenue Market Share by Application (2020-2031)
5.3 Global Major Depressive Disorder Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb Company
6.1.1 Bristol-Myers Squibb Company Company Information
6.1.2 Bristol-Myers Squibb Company Description and Business Overview
6.1.3 Bristol-Myers Squibb Company Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bristol-Myers Squibb Company Major Depressive Disorder Drug Product Portfolio
6.1.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.2 Cerecor Inc.
6.2.1 Cerecor Inc. Company Information
6.2.2 Cerecor Inc. Description and Business Overview
6.2.3 Cerecor Inc. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cerecor Inc. Major Depressive Disorder Drug Product Portfolio
6.2.5 Cerecor Inc. Recent Developments/Updates
6.3 e-Therapeutics Plc
6.3.1 e-Therapeutics Plc Company Information
6.3.2 e-Therapeutics Plc Description and Business Overview
6.3.3 e-Therapeutics Plc Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 e-Therapeutics Plc Major Depressive Disorder Drug Product Portfolio
6.3.5 e-Therapeutics Plc Recent Developments/Updates
6.4 Eli Lilly and Company
6.4.1 Eli Lilly and Company Company Information
6.4.2 Eli Lilly and Company Description and Business Overview
6.4.3 Eli Lilly and Company Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Eli Lilly and Company Major Depressive Disorder Drug Product Portfolio
6.4.5 Eli Lilly and Company Recent Developments/Updates
6.5 F. Hoffmann-La Roche Ltd.
6.5.1 F. Hoffmann-La Roche Ltd. Company Information
6.5.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.5.3 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Product Portfolio
6.5.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.6 GlaxoSmithKline Plc
6.6.1 GlaxoSmithKline Plc Company Information
6.6.2 GlaxoSmithKline Plc Description and Business Overview
6.6.3 GlaxoSmithKline Plc Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GlaxoSmithKline Plc Major Depressive Disorder Drug Product Portfolio
6.6.5 GlaxoSmithKline Plc Recent Developments/Updates
6.7 H. Lundbeck A/S
6.7.1 H. Lundbeck A/S Company Information
6.7.2 H. Lundbeck A/S Description and Business Overview
6.7.3 H. Lundbeck A/S Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 H. Lundbeck A/S Major Depressive Disorder Drug Product Portfolio
6.7.5 H. Lundbeck A/S Recent Developments/Updates
6.8 Hua Medicine Ltd.
6.8.1 Hua Medicine Ltd. Company Information
6.8.2 Hua Medicine Ltd. Description and Business Overview
6.8.3 Hua Medicine Ltd. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hua Medicine Ltd. Major Depressive Disorder Drug Product Portfolio
6.8.5 Hua Medicine Ltd. Recent Developments/Updates
6.9 Intra-Cellular Therapies, Inc.
6.9.1 Intra-Cellular Therapies, Inc. Company Information
6.9.2 Intra-Cellular Therapies, Inc. Description and Business Overview
6.9.3 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Product Portfolio
6.9.5 Intra-Cellular Therapies, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Major Depressive Disorder Drug Industry Chain Analysis
7.2 Major Depressive Disorder Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Major Depressive Disorder Drug Production Mode & Process Analysis
7.4 Major Depressive Disorder Drug Sales and Marketing
7.4.1 Major Depressive Disorder Drug Sales Channels
7.4.2 Major Depressive Disorder Drug Distributors
7.5 Major Depressive Disorder Drug Customer Analysis
8 Major Depressive Disorder Drug Market Dynamics
8.1 Major Depressive Disorder Drug Industry Trends
8.2 Major Depressive Disorder Drug Market Drivers
8.3 Major Depressive Disorder Drug Market Challenges
8.4 Major Depressive Disorder Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Major Depressive Disorder Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Major Depressive Disorder Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Major Depressive Disorder Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Major Depressive Disorder Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Major Depressive Disorder Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Major Depressive Disorder Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Major Depressive Disorder Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Major Depressive Disorder Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Major Depressive Disorder Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Major Depressive Disorder Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Major Depressive Disorder Drug, Product Type & Application
Table 12. Global Key Manufacturers of Major Depressive Disorder Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Major Depressive Disorder Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Major Depressive Disorder Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Major Depressive Disorder Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Major Depressive Disorder Drug Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Major Depressive Disorder Drug Sales Market Share by Region (2020-2025)
Table 19. Global Major Depressive Disorder Drug Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Major Depressive Disorder Drug Sales Market Share by Region (2026-2031)
Table 21. Global Major Depressive Disorder Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Major Depressive Disorder Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Major Depressive Disorder Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Major Depressive Disorder Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Major Depressive Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Major Depressive Disorder Drug Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Major Depressive Disorder Drug Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Major Depressive Disorder Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Major Depressive Disorder Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Major Depressive Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Major Depressive Disorder Drug Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Major Depressive Disorder Drug Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Major Depressive Disorder Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Major Depressive Disorder Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Major Depressive Disorder Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Major Depressive Disorder Drug Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Major Depressive Disorder Drug Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Major Depressive Disorder Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Major Depressive Disorder Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Major Depressive Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Major Depressive Disorder Drug Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Major Depressive Disorder Drug Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Major Depressive Disorder Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Major Depressive Disorder Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Major Depressive Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Major Depressive Disorder Drug Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Major Depressive Disorder Drug Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Major Depressive Disorder Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Major Depressive Disorder Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Major Depressive Disorder Drug Sales (K Pcs) by Type (2020-2025)
Table 51. Global Major Depressive Disorder Drug Sales (K Pcs) by Type (2026-2031)
Table 52. Global Major Depressive Disorder Drug Sales Market Share by Type (2020-2025)
Table 53. Global Major Depressive Disorder Drug Sales Market Share by Type (2026-2031)
Table 54. Global Major Depressive Disorder Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Major Depressive Disorder Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Major Depressive Disorder Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Major Depressive Disorder Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Major Depressive Disorder Drug Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Major Depressive Disorder Drug Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Major Depressive Disorder Drug Sales (K Pcs) by Application (2020-2025)
Table 61. Global Major Depressive Disorder Drug Sales (K Pcs) by Application (2026-2031)
Table 62. Global Major Depressive Disorder Drug Sales Market Share by Application (2020-2025)
Table 63. Global Major Depressive Disorder Drug Sales Market Share by Application (2026-2031)
Table 64. Global Major Depressive Disorder Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Major Depressive Disorder Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Major Depressive Disorder Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Major Depressive Disorder Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Major Depressive Disorder Drug Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Major Depressive Disorder Drug Price (USD/Pcs) by Application (2026-2031)
Table 70. Bristol-Myers Squibb Company Company Information
Table 71. Bristol-Myers Squibb Company Description and Business Overview
Table 72. Bristol-Myers Squibb Company Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Bristol-Myers Squibb Company Major Depressive Disorder Drug Product
Table 74. Bristol-Myers Squibb Company Recent Developments/Updates
Table 75. Cerecor Inc. Company Information
Table 76. Cerecor Inc. Description and Business Overview
Table 77. Cerecor Inc. Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Cerecor Inc. Major Depressive Disorder Drug Product
Table 79. Cerecor Inc. Recent Developments/Updates
Table 80. e-Therapeutics Plc Company Information
Table 81. e-Therapeutics Plc Description and Business Overview
Table 82. e-Therapeutics Plc Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. e-Therapeutics Plc Major Depressive Disorder Drug Product
Table 84. e-Therapeutics Plc Recent Developments/Updates
Table 85. Eli Lilly and Company Company Information
Table 86. Eli Lilly and Company Description and Business Overview
Table 87. Eli Lilly and Company Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Eli Lilly and Company Major Depressive Disorder Drug Product
Table 89. Eli Lilly and Company Recent Developments/Updates
Table 90. F. Hoffmann-La Roche Ltd. Company Information
Table 91. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 92. F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Product
Table 94. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 95. GlaxoSmithKline Plc Company Information
Table 96. GlaxoSmithKline Plc Description and Business Overview
Table 97. GlaxoSmithKline Plc Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. GlaxoSmithKline Plc Major Depressive Disorder Drug Product
Table 99. GlaxoSmithKline Plc Recent Developments/Updates
Table 100. H. Lundbeck A/S Company Information
Table 101. H. Lundbeck A/S Description and Business Overview
Table 102. H. Lundbeck A/S Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. H. Lundbeck A/S Major Depressive Disorder Drug Product
Table 104. H. Lundbeck A/S Recent Developments/Updates
Table 105. Hua Medicine Ltd. Company Information
Table 106. Hua Medicine Ltd. Description and Business Overview
Table 107. Hua Medicine Ltd. Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Hua Medicine Ltd. Major Depressive Disorder Drug Product
Table 109. Hua Medicine Ltd. Recent Developments/Updates
Table 110. Intra-Cellular Therapies, Inc. Company Information
Table 111. Intra-Cellular Therapies, Inc. Description and Business Overview
Table 112. Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Product
Table 114. Intra-Cellular Therapies, Inc. Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Major Depressive Disorder Drug Distributors List
Table 118. Major Depressive Disorder Drug Customers List
Table 119. Major Depressive Disorder Drug Market Trends
Table 120. Major Depressive Disorder Drug Market Drivers
Table 121. Major Depressive Disorder Drug Market Challenges
Table 122. Major Depressive Disorder Drug Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report


List of Figures
Figure 1. Product Picture of Major Depressive Disorder Drug
Figure 2. Global Major Depressive Disorder Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Major Depressive Disorder Drug Market Share by Type: 2024 & 2031
Figure 4. Aripiprazole Product Picture
Figure 5. AV-101 Product Picture
Figure 6. AVP-786 Product Picture
Figure 7. Basimglurant Product Picture
Figure 8. Brexpiprazole Product Picture
Figure 9. Others Product Picture
Figure 10. Global Major Depressive Disorder Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Major Depressive Disorder Drug Market Share by Application: 2024 & 2031
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Research Center
Figure 15. Global Major Depressive Disorder Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Major Depressive Disorder Drug Market Size (2020-2031) & (US$ Million)
Figure 17. Global Major Depressive Disorder Drug Sales (2020-2031) & (K Pcs)
Figure 18. Global Major Depressive Disorder Drug Average Price (USD/Pcs) & (2020-2031)
Figure 19. Major Depressive Disorder Drug Report Years Considered
Figure 20. Major Depressive Disorder Drug Sales Share by Manufacturers in 2024
Figure 21. Global Major Depressive Disorder Drug Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Major Depressive Disorder Drug Players: Market Share by Revenue in Major Depressive Disorder Drug in 2024
Figure 23. Major Depressive Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Major Depressive Disorder Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Major Depressive Disorder Drug Sales Market Share by Country (2020-2031)
Figure 26. North America Major Depressive Disorder Drug Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Major Depressive Disorder Drug Sales Market Share by Country (2020-2031)
Figure 30. Europe Major Depressive Disorder Drug Revenue Market Share by Country (2020-2031)
Figure 31. Germany Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Major Depressive Disorder Drug Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Major Depressive Disorder Drug Revenue Market Share by Region (2020-2031)
Figure 38. China Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Major Depressive Disorder Drug Sales Market Share by Country (2020-2031)
Figure 49. Latin America Major Depressive Disorder Drug Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Major Depressive Disorder Drug Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Major Depressive Disorder Drug Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. U.A.E Major Depressive Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Major Depressive Disorder Drug by Type (2020-2031)
Figure 59. Global Revenue Market Share of Major Depressive Disorder Drug by Type (2020-2031)
Figure 60. Global Major Depressive Disorder Drug Price (USD/Pcs) by Type (2020-2031)
Figure 61. Global Sales Market Share of Major Depressive Disorder Drug by Application (2020-2031)
Figure 62. Global Revenue Market Share of Major Depressive Disorder Drug by Application (2020-2031)
Figure 63. Global Major Depressive Disorder Drug Price (USD/Pcs) by Application (2020-2031)
Figure 64. Major Depressive Disorder Drug Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies